April 2023 — Pharma News Archive

Every regulatory action (92), Phase 3 readout (0), and patent expiry (11) tracked in April 2023. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

92 regulatory actions 0 Phase 3 readouts 11 patent expiries

Regulatory actions (92)

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (11)

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

See also